• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number S-45-120-120-P6
Device Problems Patient-Device Incompatibility (2682); Migration (4003)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 10/08/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat a lesion in the superficial femoral artery (sfa).A guide wire was advanced and pre-dilatation was performed with a balloon.The 4.5x120mm super self-expanding stent system (sess) was implanted.However, thrombus was generated in the target vessel due to poor adherence to the wall and the stent was displaced to the distal end.A snare device was used to remove the stent immediately and the clot subsequently disappeared on its own without surgical intervention.Another 5.5mm supera stent was implanted and completed the procedure.There was no adverse patient sequelae.There was no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported patient-device incompatibility-wall apposition and the reported migration-stent were unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effect of thrombosis is listed in the supera peripheral stent system instructions for use (ifu) as potential adverse effects of peripheral percutaneous intervention.It is possible that during initial deployment the diameter of the stent used was inadvertently undersized for the size of the vessel; thus resulting in the reported patient-device incompatibility wall apposition and ultimately resulted in the reported stent migration; however this cannot be confirmed.The investigation determined a conclusive cause for the reported patient-device incompatibility wall apposition and the reported stent migration cannot be determined.As there was no damage noted to the device during the inspection prior to use, it is likely that inadvertent mishandling resulted in the noted device damages (pinched sheath, separated tip jacket/inner member).The reported difficulties possibly caused/contributed to the reported patient effects; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18029941
MDR Text Key326855974
Report Number2024168-2023-11950
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648226007
UDI-Public08717648226007
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberS-45-120-120-P6
Device Lot Number3032461
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/16/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/10/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/24/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
7F GUIDING CATHETER
Patient Outcome(s) Required Intervention;
-
-